Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Moll

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Biomedicines|October 27, 2022
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological RiskMarcin Miszczyk, Monika Szołtysik, Maja Hasterok, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 8, 2023
Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysisMarcin Miszczyk, Agata Suleja, Szymon Sobel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 3, 2024
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boostMatthias Moll, Łukasz Magrowski, Martina Mittlböck, et al.
Biomedicines|October 27, 2022
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing RadiotherapyŁukasz Magrowski, Oliwia Masri, Jakub Ciepał, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2023
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patientsMarcin Miszczyk, Łukasz Magrowski, Tomasz Krzysztofiak, et al.
Cell Reports|December 3, 2015
Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample OxygenIsabel Siegert, Johannes Schödel, Manfred Nairz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2026
Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysisMarcin Miszczyk, Nishan Sohoni, Shayan Smani, et al.
European Urology Oncology|October 16, 2023
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European StudyPawel Rajwa, Daniele Robesti, Michael Chaloupka, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Biomedicines|October 27, 2022
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological RiskMarcin Miszczyk, Monika Szołtysik, Maja Hasterok, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 8, 2023
Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysisMarcin Miszczyk, Agata Suleja, Szymon Sobel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 3, 2024
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boostMatthias Moll, Łukasz Magrowski, Martina Mittlböck, et al.
Biomedicines|October 27, 2022
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing RadiotherapyŁukasz Magrowski, Oliwia Masri, Jakub Ciepał, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2023
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patientsMarcin Miszczyk, Łukasz Magrowski, Tomasz Krzysztofiak, et al.
Cell Reports|December 3, 2015
Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample OxygenIsabel Siegert, Johannes Schödel, Manfred Nairz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2026
Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysisMarcin Miszczyk, Nishan Sohoni, Shayan Smani, et al.
European Urology Oncology|October 16, 2023
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European StudyPawel Rajwa, Daniele Robesti, Michael Chaloupka, et al.
Pageof 3